Supriya Lifescience informs shareholders on TDS rules for final dividend Re.1

Supriya Lifescience has informed shareholders about tax deduction at source on its recommended final dividend of Re. 1 (50 percent) per equity share of face value Rs. 2 for FY 2025-26, pending AGM approval. TDS at 10 percent applies to resident shareholders under Section 393(1) of the Income Tax Act; non-residents face 20 percent plus surcharge and cess. Individuals with total dividend up to Rs. 10,000 are exempt. Shareholders must submit PAN, residential status, and declaration forms to RTA MUFG Intime by July 15, 2026 to avoid higher TDS.